• Теги
    • избранные теги
    • Компании490
      • Показать ещё
      Разное99
      • Показать ещё
      Международные организации7
      • Показать ещё
      Страны / Регионы78
      • Показать ещё
      Люди11
      • Показать ещё
      Показатели16
      • Показать ещё
      Формат1
      Издания3
      Сферы1
Vertex Pharmaceuticals
19 января, 16:37

Vertex Pharma (VRTX) Q4 Earnings: Stock Likely to Beat?

We expect biotech company Vertex Pharmaceuticals, Inc. (VRTX) to beat expectations when it reports fourth-quarter 2016 and full-year earnings results on Jan 25, after the market closes.

18 января, 20:38

Concert Offers Update on Cystic Fibrosis Drug, Stock Down

Concert Pharmaceuticals, Inc. (CNCE) provided update on the development plan of its next generation CFTR potentiator, CTP-656, for the treatment of cystic fibrosis in the U.S. and Europe.

18 января, 16:38

Why Vertex Pharmaceuticals (VRTX) Could Be Positioned for a Surge

Vertex Pharmaceuticals (VRTX) has seen positive earnings estimate revisions for the current quarter and year, in addition to decent short-term price momentum.

12 января, 16:43

Merck KGaA, Vertex Announce Tie-Up for Oncology Programs

Merck (MKGAF) and Vertex (VRTX) collaborated for the development and commercialization of four research and development programs for the treatment of cancer.

11 января, 17:13

Biotech Stock Roundup: ARIAD to be Acquired for $5.2B, Vertex Outlook Falls Short

Several licensing deals and agreements were announced this week including the $5.2 billion ARIAD (ARIA) acquisition.

09 января, 16:10

Vertex Pharma Issues Disappointing 2017 Orkambi Outlook

Vertex Pharmaceuticals Incorporated (VRTX) announced preliminary financial results for 2016 and issued a financial outlook for 2017 on Jan 8, ahead of a Jan 9 presentation at the JP Morgan healthcare conference in San Francisco.

03 января, 16:53

Is Vertex Pharma (VRTX) Poised for a Turnaround in 2017?

Vertex Pharmaceuticals, Inc.'s (VRTX) main therapeutic area of focus is cystic fibrosis (CF). Presently, the company markets two medicines for the disease, Kalydeco and Orkambi.

29 декабря 2016, 15:12

Regeneron vs. Vertex: Which Stock is a Better Pick?

Both Regeneron (REGN) and Vertex look set for a rebound in 2017 after a tough and challenging 2016.

28 декабря 2016, 09:36

Consumers Haven't Felt This Good in 15 Years

Consumers Haven't Felt This Good in 15 Years

27 декабря 2016, 18:58

Stock Market News for December 27, 2016

Major U.S. benchmarks ended the last trading session ahead of Christmas holiday on a positive note as investors continued to cheer Trump's promises.

23 декабря 2016, 17:30

Zacks.com featured highlights: Abercrombie & Fitch, Live Nation Entertainment, Herc Holdings, Conns and Vertex Pharmaceuticals

Zacks.com featured highlights: Abercrombie & Fitch, Live Nation Entertainment, Herc Holdings, Conns and Vertex Pharmaceuticals

22 декабря 2016, 14:38

5 Toxic Stocks to Remove from Your Portfolio or Play Short

Elevated price levels of toxic stocks can be due to either an irrational exuberance associated with them or some serious fundamental lacunae.

20 декабря 2016, 19:23

Intro Guide to the Fidelity Select Biotechnology Fund (FBIOX)

Fidelity Select Biotechnology (FBIOX) a Zacks Rank #2 (Buy) seeks capital appreciation.

09 декабря 2016, 00:19

5 Drug Stocks to Avoid as Trump Vows to Lower Drug Prices

For those who thought that the pharma/biotech sector is in for an extraordinary run after Donald Trump's unexpected victory, his latest vow to crack down on excessive drug price hikes comes as a bolt from the blue.

29 ноября 2016, 16:57

Nivalis (NVLS) Cystic Fibrosis Study Misses Primary Endpoint

Nivalis Therapeutics' (NVLS) lead candidate cavosonstat failed to meet the primary endpoint of an improvement in lung function in a phase II cystic fibrosis study.

22 ноября 2016, 17:30

Zacks.com featured highlights: Allegheny Technologies, salesforce.com, United States Steel, Vertex Pharmaceuticals and Continental Resources

Zacks.com featured highlights: Allegheny Technologies, salesforce.com, United States Steel, Vertex Pharmaceuticals and Continental Resources

21 ноября 2016, 17:09

5 Toxic Stocks to Get Rid Of or Play Short Right Now

Higher prices of toxic stocks can be ascribed to either an irrational exuberance associated with them or some serious fundamental drawbacks.

07 ноября 2016, 17:30

The Zacks Analyst Blog Highlights: Cabot Oil & Gas, Zayo Group Holdings, Etsy, Live Nation Entertainment and Vertex Pharmaceuticals

The Zacks Analyst Blog Highlights: Cabot Oil & Gas, Zayo Group Holdings, Etsy, Live Nation Entertainment and Vertex Pharmaceuticals

04 ноября 2016, 17:49

5 Toxic Stocks to Cast Aside or Play Short

Unjustifiably high price of toxic stocks is short-lived as their current price is higher than their intrinsic value and these are bound to result into loss for investors over time.

31 октября 2016, 16:25

Nivalis (NVLS) Q3 Earnings Preview: Can the Stock Surprise?

Nivalis Therapeutics, Inc. (NVLS) is expected to report third-quarter 2016 results on Nov 7. Last quarter, the company posted a negative surprise of 5.77%.